Terms: = Colorectal cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Staging
31 results:
1. Molecular and Clinicopathological Differences by Age at the Diagnosis of colorectal cancer.
Chang CC; Lin PC; Lin CC; Lan YT; Lin HH; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK; Lin JK; Chang SC
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678173
[TBL] [Abstract] [Full Text] [Related]
2. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
[TBL] [Abstract] [Full Text] [Related]
3. k-ras gene mutation as an early prognostic marker of colon cancer.
Szpon Ł; Stal A; Zawadzki M; Lis-Nawara A; Kielan W; Grzebieniak Z
Pol Przegl Chir; 2016 Jan; 88(1):15-9. PubMed ID: 27096769
[TBL] [Abstract] [Full Text] [Related]
4. TNMF versus TNM in staging of colorectal cancer.
Ahmed Farag AF; Elbarmelgi MY; Azim HA; Abozeid AA; Mashhour AN
Int J Surg; 2016 Mar; 27():147-150. PubMed ID: 26836283
[TBL] [Abstract] [Full Text] [Related]
5. Is k-ras gene mutation a prognostic factor for colorectal cancer: a systematic review and meta-analysis.
Ren J; Li G; Ge J; Li X; Zhao Y
Dis Colon Rectum; 2012 Aug; 55(8):913-23. PubMed ID: 22810479
[TBL] [Abstract] [Full Text] [Related]
6. Epigenetic alteration of DNA in mucosal wash fluid predicts invasiveness of colorectal tumors.
Kamimae S; Yamamoto E; Yamano HO; Nojima M; Suzuki H; Ashida M; Hatahira T; Sato A; Kimura T; Yoshikawa K; Harada T; Hayashi S; Takamaru H; Maruyama R; Kai M; Nishiwaki M; Sugai T; Sasaki Y; Tokino T; Shinomura Y; Imai K; Toyota M
Cancer Prev Res (Phila); 2011 May; 4(5):674-83. PubMed ID: 21543345
[TBL] [Abstract] [Full Text] [Related]
7. Clinical significance of k-ras and BRAF mutations in Chinese colorectal cancer patients.
Shen H; Yuan Y; Hu HG; Zhong X; Ye XX; Li MD; Fang WJ; Zheng S
World J Gastroenterol; 2011 Feb; 17(6):809-16. PubMed ID: 21390154
[TBL] [Abstract] [Full Text] [Related]
8. [Morphology as the starting point for individualized cancer treatment].
Ortega JS
An R Acad Nac Med (Madr); 2009; 126(1):127-39; discussion 140-5. PubMed ID: 20432663
[TBL] [Abstract] [Full Text] [Related]
9. Molecular detection (k-ras) of exfoliated tumour cells in the pelvis is a prognostic factor after resection of rectal cancer?
Kristensen AT; Wiig JN; Larsen SG; Giercksky KE; Ekstrøm PO
BMC Cancer; 2008 Jul; 8():213. PubMed ID: 18655729
[TBL] [Abstract] [Full Text] [Related]
10. From colonic polyps to colon cancer: pathophysiology, clinical presentation, screening and colonoscopic therapy.
Cappell MS
Minerva Gastroenterol Dietol; 2007 Dec; 53(4):351-73. PubMed ID: 18043553
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer.
Maurer GD; Leupold JH; Schewe DM; Biller T; Kates RE; Hornung HM; Lau-Werner U; Post S; Allgayer H
Clin Cancer Res; 2007 Feb; 13(4):1123-32. PubMed ID: 17317820
[TBL] [Abstract] [Full Text] [Related]
12. Microdissection-based allelotyping: a novel technique to determine the temporal sequence and biological aggressiveness of colorectal cancer.
Gamblin TC; Finkelstein SD; Upsal N; Kaye JD; Blumberg D
Am Surg; 2006 May; 72(5):445-53. PubMed ID: 16719202
[TBL] [Abstract] [Full Text] [Related]
13. Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and k-ras mutations.
Kim IJ; Kang HC; Jang SG; Kim K; Ahn SA; Yoon HJ; Yoon SN; Park JG
Carcinogenesis; 2006 Mar; 27(3):392-404. PubMed ID: 16219636
[TBL] [Abstract] [Full Text] [Related]
14. Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer.
Frigola J; Solé X; Paz MF; Moreno V; Esteller M; Capellà G; Peinado MA
Hum Mol Genet; 2005 Jan; 14(2):319-26. PubMed ID: 15574462
[TBL] [Abstract] [Full Text] [Related]
15. Genetic alterations in locally advanced stage II/III colon cancer: a search for prognostic markers.
Westra JL; Plukker JT; Buys CH; Hofstra RM
Clin Colorectal Cancer; 2004 Nov; 4(4):252-9. PubMed ID: 15555207
[TBL] [Abstract] [Full Text] [Related]
16. k-ras point mutation, and amplification of C-MYC and C-ERBB2 in colon adenocarcinoma.
Kruszewski W; Kowara R; Rzepko R; Warezak C; Zieliński J; Gryglewski G; Kopacz A; Jastrzebski T; Pawełczyk T
Folia Histochem Cytobiol; 2004; 42(3):173-9. PubMed ID: 15493579
[TBL] [Abstract] [Full Text] [Related]
17. Peptide nucleic acid clamp PCR: a novel k-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes.
Taback B; Bilchik AJ; Saha S; Nakayama T; Wiese DA; Turner RR; Kuo CT; Hoon DS
Int J Cancer; 2004 Sep; 111(3):409-14. PubMed ID: 15221969
[TBL] [Abstract] [Full Text] [Related]
18. Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis.
Kolligs FT; Bommer G; Göke B
Digestion; 2002; 66(3):131-44. PubMed ID: 12481159
[TBL] [Abstract] [Full Text] [Related]
19. Extended staging results from the detection of isolated tumor cells in the liver of colorectal cancer patients.
Schimanski CC; Linnemann U; Arbogast R; Berger MR
Oncol Rep; 2001; 8(1):185-8. PubMed ID: 11115595
[TBL] [Abstract] [Full Text] [Related]
20. Molecular staging of colorectal cancer: k-ras mutation analysis of lymph nodes upstages Dukes B patients.
Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR
Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887
[TBL] [Abstract] [Full Text] [Related]
[Next]
